Detalles de la búsqueda
1.
The Association Between Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Post-COVID-19 Syndrome in Healthcare Workers.
J Infect Dis;
223(10): 1671-1676, 2021 05 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33675366
2.
Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection.
Kidney Int;
99(6): 1470-1477, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33774082
3.
Durable humoral responses after the second anti-SARS-CoV-2 vaccine dose in chronic myeloid leukaemia patients on tyrosine kinase inhibitors.
Br J Haematol;
197(1): e1-e4, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34923623
4.
SARS-CoV-2 antibody responses associate with sex, age and disease severity in previously uninfected people admitted to hospital with COVID-19: An ISARIC4C prospective study.
Front Immunol;
14: 1146702, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37056776
5.
Simple, sensitive, specific self-sampling assay secures SARS-CoV-2 antibody signals in sero-prevalence and post-vaccine studies.
Sci Rep;
12(1): 1885, 2022 02 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35115570
6.
Detection and quantification of antibody to SARS CoV 2 receptor binding domain provides enhanced sensitivity, specificity and utility.
J Virol Methods;
302: 114475, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35077719
7.
SARS-CoV-2 lateral flow assays for possible use in national covid-19 seroprevalence surveys (React 2): diagnostic accuracy study.
BMJ;
372: n423, 2021 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33653694
8.
Long-term persistence of natural anti-SARS-CoV-2 antibodies and mild impact of SARS-CoV-2 infection in CML patients: results from a seroprevalence study.
Leuk Lymphoma;
63(6): 1504-1507, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35068289
Resultados
1 -
8
de 8
1
Próxima >
>>